316 related articles for article (PubMed ID: 27590033)
1. Platelet inhibition and bleeding complications in cardiac surgery: A review.
Hansson EC; Jeppsson A
Scand Cardiovasc J; 2016; 50(5-6):349-354. PubMed ID: 27590033
[TBL] [Abstract][Full Text] [Related]
2. Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy?
Mahla E; Tantry US; Prüller F; Gurbel PA
Circulation; 2018 Nov; 138(19):2145-2159. PubMed ID: 30474416
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study.
O'Connor SA; Amour J; Mercadier A; Martin R; Kerneis M; Abtan J; Brugier D; Silvain J; Barthélémy O; Leprince P; Montalescot G; Collet JP;
Circ Cardiovasc Interv; 2015 Nov; 8(11):e002786. PubMed ID: 26553698
[TBL] [Abstract][Full Text] [Related]
4. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
Rosengart TK; Romeiser JL; White LJ; Fratello A; Fallon E; Senzel L; Shroyer AL
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266. PubMed ID: 23953984
[TBL] [Abstract][Full Text] [Related]
5. Platelet function testing to time surgery in patients on dual antiplatelet therapy?
Mahla E; Raggam R; Toller W
Hamostaseologie; 2014; 34(1):40-5. PubMed ID: 24071994
[TBL] [Abstract][Full Text] [Related]
6. Bleeding Risk Prediction in Patients With Dual Antiplatelet Therapy Undergoing Coronary Artery Bypass Grafting Surgery Using a Rapid Point-of-Care Platelet Function Test.
Tello-Montoliu A; Albaladejo P; Hernández-Romero D; Taboada R; Albacete CL; Arribas JM; Jara R; Veliz A; López-García C; Cánovas S; Valdés M; Rivera-Caravaca JM; Marín F
Circ Cardiovasc Interv; 2018 Dec; 11(12):e007264. PubMed ID: 30525983
[No Abstract] [Full Text] [Related]
7. Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome.
Paravattil B; Elewa H
J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):347-355. PubMed ID: 28587584
[TBL] [Abstract][Full Text] [Related]
8. Major Bleeding after Surgical Revascularization with Dual Antiplatelet Therapy.
Schlachtenberger G; Deppe AC; Gerfer S; Choi YH; Zeriouh M; Liakopoulos O; Wahlers TCW
Thorac Cardiovasc Surg; 2020 Dec; 68(8):714-722. PubMed ID: 32593177
[TBL] [Abstract][Full Text] [Related]
9. Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery.
Ranucci M; Colella D; Baryshnikova E; Di Dedda U;
Br J Anaesth; 2014 Dec; 113(6):970-6. PubMed ID: 25209096
[TBL] [Abstract][Full Text] [Related]
10. A model-based analysis of the clinical and economic impact of personalising P2Y12-receptor inhibition with platelet function testing in acute coronary syndrome patients.
Straub N; Beivers A; Lenk E; Aradi D; Sibbing D
Thromb Haemost; 2014 Feb; 111(2):290-9. PubMed ID: 24154566
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study.
Jackson LR; Ju C; Zettler M; Messenger JC; Cohen DJ; Stone GW; Baker BA; Effron M; Peterson ED; Wang TY
JACC Cardiovasc Interv; 2015 Dec; 8(14):1880-9. PubMed ID: 26718518
[TBL] [Abstract][Full Text] [Related]
12. Preoperative platelet transfusions to reverse antiplatelet therapy for urgent non-cardiac surgery: an observational cohort study.
Baschin M; Selleng S; Hummel A; Diedrich S; Schroeder HW; Kohlmann T; Westphal A; Greinacher A; Thiele T
J Thromb Haemost; 2018 Apr; 16(4):709-717. PubMed ID: 29383871
[TBL] [Abstract][Full Text] [Related]
13. The association between a three-day ticagrelor discontinuation and perioperative bleeding complications.
Kremke M; Gissel MS; Jensen MJ; Thomassen SA; Jakobsen CJ
Eur J Cardiothorac Surg; 2019 Apr; 55(4):714-720. PubMed ID: 30358828
[TBL] [Abstract][Full Text] [Related]
14. [Bleeding in patients receiving dual antiplatelet therapy after acute coronary syndrome - significance, prevention and interdisciplinary management].
Zeymer U; Koscielny J; von Heymann C; Spannagl M; Labenz J; Cremer J; Giannitsis E; Darius H; Goss F
Dtsch Med Wochenschr; 2016 Jul; 141(15):1107-11. PubMed ID: 27464285
[TBL] [Abstract][Full Text] [Related]
15. Exploration of efficacy and bleeding with combined phosphoinositide 3-kinase β inhibition and aspirin in man.
Nylander S; Wågberg F; Andersson M; Skärby T; Gustafsson D
J Thromb Haemost; 2015 Aug; 13(8):1494-502. PubMed ID: 26096765
[TBL] [Abstract][Full Text] [Related]
16. Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?
Mahla E; Prueller F; Farzi S; Pregartner G; Raggam RB; Beran E; Toller W; Berghold A; Tantry US; Gurbel PA
Ann Thorac Surg; 2016 Dec; 102(6):2010-2017. PubMed ID: 27378554
[TBL] [Abstract][Full Text] [Related]
17. Shorter (≤6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials.
Pandit A; Giri S; Hakim FA; Fortuin FD
Catheter Cardiovasc Interv; 2015 Jan; 85(1):34-40. PubMed ID: 24753084
[TBL] [Abstract][Full Text] [Related]
18. The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders.
Bernlochner I; Byrne RA; Kastrati A; Sibbing D
Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):999-1014. PubMed ID: 21878045
[TBL] [Abstract][Full Text] [Related]
19. Platelet function recovery after ticagrelor withdrawal in patients awaiting urgent coronary surgery.
Hansson EC; Malm CJ; Hesse C; Hornestam B; Dellborg M; Rexius H; Jeppsson A
Eur J Cardiothorac Surg; 2017 Apr; 51(4):633-637. PubMed ID: 28007881
[TBL] [Abstract][Full Text] [Related]
20. Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society for Anaesthesia and Intensive Care (SFAR).
Godier A; Garrigue D; Lasne D; Fontana P; Bonhomme F; Collet JP; de Maistre E; Ickx B; Gruel Y; Mazighi M; Nguyen P; Vincentelli A; Albaladejo P; Lecompte T;
Arch Cardiovasc Dis; 2019 Mar; 112(3):199-216. PubMed ID: 30621917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
